Home » Care & Treatment » Alzheimer's Disease

Start a new search

Alzheimer's Clinical Trials

Why join an Alzheimer's disease clinical trial?

There are many reasons why you might choose to join an Alzheimer’s disease clinical trial. You may want to:

  • Help others, including family members, who may be at risk for Alzheimer’s disease
  • Receive regular monitoring by medical professionals
  • Learn about Alzheimer’s disease and your health
  • Test new treatments
  • Get information about support groups and resources

When you choose to participate in research, you become a partner in scientific discovery—regardless of the reason why you participate. Your contribution can help future generations lead healthier lives. Major medical breakthroughs could not happen without the generosity of clinical trial participants.

Clinical Trials in the Albany Med Health System

Albany Medical Center, Glens Falls Hospital and other hospitals of the Albany Med Health System participate in clinical (human) trials in all clinical fields, including Alzheimer's disease. All clinical trials are vetted and managed through Albany Medical College.

For the latest information on trials available to patients in our area, please visit the updated list of trials at the National Institutes of Health.

You can also ask your provider about any clinical trials you might be eligible for.

Recent Clinical Trials at Albany Medical Center

Patient trials we are involved in currently or recently include:

  • Two Phase III trials sponsored by Eisai of lecanemab, an antiamyloid monoclonal antibody. The idea with such agents is that removing amyloid protein, which is deposited in the brain as neuritic plaques, may help slow progression of disease. Lecanemab was approved by the US Food and Drug Administration in July of 2023 after it was shown to delay cognitive and functional decline by approximately five months in an 18-month, double-blind, placebo-controlled trial. It is now offered at Albany Medical Center to eligible patients.
  • The Alzheimer’s Disease Neuroimaging Initiative (ADNI4) trial, which is a long-term observational study collecting exam data, neuroimaging, and other biomarker data on people with mild cognitive impairment, dementia, and in cognitively normal people as controls.

National Clinical Trials

Find more information about clinical trials from these organizations.